3637 results for «2002»
3637 results
How to improve TAVI durability - LIVE case
26 Nov 2024 – From PCR London Valves 2024
Explore two fascinating cases tackling severe aortic valve challenges with innovative approaches:
- LIVE Case: An 84-year-old woman with a history of breast cancer and TAVI (Evolut Pro 29) in 2016, presenting with symptomatic severe TAVI stenosis. CT revealed a true ID of 19 mm. The team implanted...
Rapid-Fire - TAVI and co-existent coronary artery disease
26 Nov 2024 – From PCR London Valves 2024
Explore a rapid-fire session featuring a selection of compelling clinical cases from PCR London Valves 2024. Discover how interventional cardiologists navigated complex scenarios, including overcoming late radiotherapy consequences, tackling challenging bicuspid aortic stenosis with left main disease, managing TAVI from elective to emergency, performing CTO intervention...
Recurrent and residual tricuspid regurgitation after transcatheter repair - Assessment and management
26 Nov 2024 – From PCR London Valves 2024
Join us as we delve into the critical topic of recurrent and residual tricuspid regurgitation after transcatheter repair. Gain valuable insights on how to avoid these complications, learn to assess the underlying mechanisms and severity, and explore the latest options for interventional treatment. This session, developed...
TAV-in-SAV for surgical bioprosthetic valve failure
26 Nov 2024 – From PCR London Valves 2024
Dive into the intricacies of TAV-in-SAV procedures for failed surgical bioprosthetic valves. Gain a comprehensive understanding of the key information needed to evaluate a failed surgical bioprosthesis before considering a valve-in-valve intervention. Learn strategies to avoid high gradients and patient-prosthesis mismatch, and explore the clinical relevance...
Featured research - Valves and beyond
26 Nov 2024 – From PCR London Valves 2024
This session features a selection of the latest research and insights from PCR London Valves 2024, covering a wide range of topics in valvular and structural heart interventions. Discover the early results of a new TTVR system, compare the performance of different TAVI devices, explore long-term...
AsiaPCR/SingLIVE 2017: closing Ceremony and Awards
21 Jan 2017 – From AsiaPCR/SingLIVE 2017
Consult the Closing ceremony and awards session from AsiaPCR/SingLIVE 2017, where W. Wijns addresses the subject of what to expect in the field of Interventional Cardiology in 2017, and the speakers present the award winners of this year's best clinical cases namely R. Fukuhara, Japan, W....
Chairperson
Chairperson
AsiaPCR/SingLIVE 2017: Opening Ceremony
19 Jan 2017 – From AsiaPCR/SingLIVE 2017
Consult the Opening ceremony of the AsiaPCR/SingLIVE 2017 course edition, the Chien Foundation Award for outstanding lectureship and lifetime achievement in PCI is awarded to Prof. A. Seth.
Chairperson
Alain G. Cribier
07 Nov 2017
In 2002, Alain Cribier revolutionised the field by introducing transcatheter aortic valve implantation (TAVI) as a complementary technique to surgery. Find out more about his early life and studies.
Transcatheter aortic valve implantation (TAVI)
10 Sep 2025
Aortic stenosis (AS) is the most common valvular heart disease leading to intervention. It is characterized by progression from leaflet thickening and calcification to significant haemodynamic stenosis which results in disease-specific symptoms and physical limitations as well as poor prognosis and impaired quality of life if...
Authors :
Aortic stenosis prevalence and balloon aortic valvuloplasty
08 Nov 2017
The transformation in the field of interventional cardiology is unprecedented. Today, interventional cardiology encompasses an ever-growing list of diagnostic and therapeutic percutaneous procedures performed in the cathlab.
PCRonline announces its new Editor-in-Chief!
14 Feb 2020
Salvatore Brugaletta is an Interventional Cardiologist at the “Hospital Clínic de Barcelona”, Spain and associate professor of Medicine at the University of Barcelona. Highly skilled in Clinical Research, Medical Education and Medical Devices with strong commitment inside medical communities, he received two PhD degrees focused on interventional cardiology from Erasmus University (Rotterdam,...
In remembrance of Alain Cribier
17 Feb 2024
It is with great sadness that PCR and the interventional cardiology community learnt of the death of Professor Alain Cribier, pioneer in the non-invasive treatment of valvular disease, superb doctor and professor of medicine and great humanist whose concern and care for his patients went beyond...
Elixir Medical completes enrollment in BIOADAPTOR randomized controlled trial of Dynamx Coronary Bioadaptor System
15 Feb 2022
Dynamx bioadaptor restores rotational motion and vessel stress reduction in new study
02 Jun 2022
30 years of primary PCI – a tale of perseverance
16 May 2023
Over the last 30 years, primary PCI (pPCI) has evolved from an experimental ‘rescue’ intervention to an essential routine procedure – performed daily in cathlabs around the world – which is responsible for saving millions of lives. However, its path to success was far from smooth.
A review of the 2024 ESC Guidelines on elevated blood pressure and hypertension
13 Nov 2024
Lucas Lauder and Felix Mahfoud provide a summary of the ESC Guidelines on elevated blood pressure and hypertension presented by John William McEvoy and Rhian Touyz at ESC Congress 2024 in London.
Author
Author
Drug-coated balloon (DCB) technology: A pioneer’s view of the historical evolution and future directions
08 Jan 2025
In this article, Bruno Scheller explores advances in local drug delivery, from drug-coated balloons to novel antiproliferative agents. These innovations aim to reduce restenosis, minimize permanent implants, and pave the way for patient-specific coronary artery disease treatments.
Author
